Germany's High-Tech Strategy - Unlocking Innovative Potential
Health research and development and biotechnology play a significant role in Germany’s High-Tech Strategy as the country prepares to meet the challenges of the 21st century. The innovative potential of the health sector is being unlocked through new health care delivery and knowledge/technology transfer models.
Germany is the world's third biggest medical technology producer and medical services provider. It is also the global number two in biotech medical solutions key to therapeutic drug and regenerative medicine development.
Germany's health sector is one of the largest industries in the country, accounting for more than 10 percent of GDP and boasting a workforce more than 4 million strong. Approaching a million new jobs will be created in the sector by 2020 as Germany pursues its High-Tech Strategy goals.
High-Tech Strategy 2020
The High-Tech Strategy 2020 identifies five broad areas in which Germany is striving to attain lead provider of science and technology-based solutions status by 2020. These are:
High-Tech Strategy 2020 Action Plan - Forward-looking Projects (Health)
The German government passed the High-Tech Strategy Action Plan in March 2012 for the further implementation of the High-Tech Strategy.
Ten so-called "forward-looking projects" are the focus of research and innovation policy as part of the High-Tech Strategy 2020 Action Plan. Specific objectives are pursued within these projects over a period of 10 to 15 years.
Three of the High-Tech Strategy 2020 Action Plan's 10 forward-looking projects are health related in nature.